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tality rate. OAR is associated with a mortality rate of
approximately 4% in institutional series and 6% to 10% in
regional or national studies.5-8 Coronary artery disease
(CAD), the most prominent risk factor, is responsible for
up to 60% of perioperative deaths after OAR.6,7,9 Adverse
cardiac events have been attributed to excessive stress on
the myocardium caused by the combined effect of anes-
thetic induction, aortic clamping and declamping, opera-
tive blood loss, and associated hemodynamic and
metabolic changes.10,11 It is likely that hemodynamic alter-
ations associated with endovascular aneurysm repair (EAR)
are less severe. If this assumption is true, myocardial stress
will be reduced, and the risk of cardiac complications will
be minimized. At the present time, no comprehensive
studies are available on hemodynamics and left ventricular
response during endovascular AAA treatment. Neither
have proper comparisons with open AAA repair been per-
formed for clinical cardiac outcome events and findings at
hemodynamic and cardiac examinations. Apart from elec-
trocardiographic analysis, left ventricular wall imaging has
Endovascular repair of abdominal aortic aneurysms
(AAAs) is currently being evaluated as an alternative to
open aneurysm repair (OAR). Several reports have estab-
lished the feasibility and potentially low operative risks of
this less invasive technique.1-4 Indeed, one of the principal
challenges for stent-graft treatment will be to demonstrate
that it is associated with a significantly lower operative mor-
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Purpose: The purpose of this study was to assess and to compare perioperative changes in left ventricular function and
the incidence of adverse cardiac events in two groups of patients with abdominal aortic aneurysms, one during endovas-
cular aneurysm repair (EAR) and the other during open aneurysm repair (OAR).
Methods: One hundred twenty consecutive patients who underwent EAR (49 patients) or OAR (71 patients) were prospec-
tively studied. During the operation, the left ventricular function was assessed by the recording of the left ventricle stroke
work index (SWI) and the cardiac index (CI) with a pulmonary artery catheter. Measurements were performed before,
during, and after stent-graft deployment or aortic cross-clamping. Both maneuvers were defined as aortic occlusion (AO).
Transesophageal echocardiography was performed to identify signs of wall motion abnormalities of the left ventricular
wall, which indicated myocardial ischemia. Six-lead electrocardiograph monitoring was maintained until discharge from
the intensive care unit. Postoperative cardiac complications were diagnosed by clinical observation, 12-lead ECG analysis
at 1, 3, and 7 days after the operation, transthoracic echocardiography at 1 month, and measurement of cardiac enzymes.
Results: The two study groups were comparable with regard to most clinical aspects. The baseline myocardial perfor-
mance was worse in patients who underwent EAR compared with patients who underwent OAR, as indicated by a
reduced SWI (33.1 and 37.4, respectively; P = .03). During AO there was a comparable increase of the CI in both
groups. However, after AO the rise in CI was higher in patients who underwent OAR compared with patients who
underwent EAR (0.7 and 0.2, respectively; P < .01), representing a more pronounced hyperdynamic state. In addition,
the SWI demonstrated a decrease in patients who underwent OAR compared with an increase in patients who under-
went EAR during AO (–1.4 and +1.9, respectively; P = .04) and after AO (–0.9 and +2.6, respectively; P = .01). These
findings represent more severe myocardial stress in patients who underwent OAR. The incidence of postoperative clin-
ical cardiac adverse events was comparable in the two study groups. However, myocardial ischemia, as indicated by elec-
trocardiography and transesophageal echocardiography, had a higher incidence in patients who underwent open
surgery as compared with patients whose condition was managed endovascularly (57% and 33%, respectively; P = .01).
Conclusion: Hemodynamic alterations during endovascular repair were not as severe as those in patients with open
surgery and indicated less myocardial stress in the former category. These findings may explain a lower incidence of
myocardial ischemia that was observed during endovascular repair. A lower frequency of clinical perioperative cardiac
events in patients undergoing endovascular treatment may ultimately be expected. (J Vasc Surg 2001;33:353-60.)
been shown to provide accurate predictors of myocardial
ischemia and cardiac complications.12-14 These findings
may be considered as surrogate parameters for adverse
events that enable meaningful conclusions on the basis of
considerably smaller numbers of patients than would be
required if only clinical outcome is studied.
At the present time, there is hardly any objective justi-
fication to recommend either EAR or OAR to most
patients as the preferred treatment. Therefore, the bearings
of a comprehensive comparison of cardiac events that are
associated with the different treatments may be consider-
able, because answers to fundamental questions may come
at hand. The aim of the present prospective study is to
assess and to compare the perioperative changes in left ven-
tricular function and the incidence of adverse cardiac events
in two groups of patients with AAA, one group during
EAR and the other group during OAR. This study was not
randomized, and the medical condition of the patient was
a consideration in treatment selection. Therefore, as a sec-
ond objective, the influence of any differences in preexist-
ing patient characteristics between the study groups,
possibly because of patient selection, was assessed.
PATIENTS AND METHODS
Between May 1996 and August 1998, 135 consecutive
patients with AAA underwent repair. Fifteen patients were
ineligible for investigation because the hemodynamic mea-
surements were unreliable due to pulmonary artery catheter
malposition (6 of these patients underwent OAR; 9 of these
patients underwent EAR). Thus 120 patients were available
for analysis, of whom 71 patients underwent OAR and 49
patients underwent EAR. Patient selection was based on the
following considerations: OAR was performed in 58
patients who had an adverse anatomy for endograft treat-
ment15 and in two patients with a contrast allergy. In addi-
tion, 11 patients with a suitable anatomy for EAR were
included in a substudy that required randomization
between OAR and EAR and were allocated to OAR. In the
OAR group, 56 patients received a tube graft, and 15
patients received a bifurcated graft; in the EAR group, all
patients received a bifurcated device. In the EAR group, the
Stentor system (Mintec, Inc, La Ciotat, France) was used in
three patients, the Vanguard system (Boston Scientific,
Oakland, NJ) was used in 28 patients, and the AneuRx sys-
tem (Medtronic, Inc, Sunnyvale, Calif) was used in 18
patients. Patient characteristics in the two treatment groups
are summarized in Table I. The study groups were compa-
rable with regard to most, but not all, clinical aspects. Most
notably, patients who underwent OAR were older than
those who underwent EAR. A substantial number of
patients in both groups had had clinically evident manifes-
tations of CAD. Three patients in the EAR group were con-
sidered unfit for OAR.
Before the operation, all patients underwent a compre-
hensive examination by the cardiologists involved in this
study (M.G., C.P.). This examination was according to a
fixed protocol and consisted of a physical examination, a
standard 12-lead electrocardiogram, and a dobutamine
(Dobutrex) stress-echocardiogram (for this analysis, a wall
motion score was calculated). The left ventricle was divided
into 13 segments, and the segmental wall motion was
graded on a 5-point scale, varying from –1 for hyperkine-
sia, to 0 for normokinesia, 1 for hypokinesia, 2 for akine-
sia, and 3 for dyskinesia.18 The wall motion score was the
sum of the segmental wall motion scores. The baseline wall
motion score of the left ventricle (ie, before dobutamine
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Table I. Patient characteristics in the two study groups
Study group
EAR* (n = 49) OAR† (n = 71)
Characteristicn n % n %
Sex (F/M) 2/47 — 10/61 —
ASA classification16
1 7 14 10 14
2 20 41 42 59
3 15 31 14 20
4 7 14 5 7
History of myocardial infarction 15 31 21 30
Previous PTCA 7 14 14 20
Previous coronary artery bypass graft 11 22 19 27
History of CAD 22 45 36 51
Preoperative b-blocker 16 33 29 41
Hypertension‡ 23 47 40 56
Smoking‡ 21 43 27 38
Diabetes‡ 3 6 5 7
COPD‡ 17 35 17 24
PTCA, Percutaneous transluminal coronary angioplasty; COPD, chronic obstructive pulmonary disease.
*Average age, 70 years (range, 66-74 years); P < .01; maximum AAA diameter, 55 mm (range, 50-60 mm).
†Average age, 73 years (range, 69-77 years); P < .01; maximum AAA diameter, 53 mm (range, 50-64 mm).
‡Patients with a Society of Vascular Surgery/International Society for Cardiovascular Surgery risk score of more than 0.17
stress) was comparable between the two groups (median, 2
[EAR] vs 0 [OAR]; P = .5). The occurrence of wall motion
abnormalities (WMAs) at the time of dobutamine stress
was also comparable (16% [EAR] vs 8.5% [OAR]; P = .3).
In this study clinicians were not blinded for the results
of the testing. The preoperative tests resulted in therapeu-
tic measures in several instances, including a change of
preoperative medication in 25 patients and supplementary
intraoperative medication in 47 patients. Overall, 59
patients had a change of medication, with an uneven dis-
tribution between the two study groups (20 patients
[41%] with EAR vs 39 patients [55%] with OAR; P = .03).
A coronary angiogram was performed when severe CAD
was suspected, which resulted in a coronary angioplasty in
three patients and a coronary bypass graft in four patients
before aneurysm repair. All seven patients with coronary
interventions underwent OAR. The study protocol was
approved by the Hospital Review Committee.
Operative procedures. Anesthesia was induced with
etomidate, pancuronium bromide (Pavulon), and fen-
tanyl. Anesthesia was maintained with nitrous oxide and
oxygen gas mixtures and fentanyl and pancuronium as
needed. General endotracheal anesthesia was used in all
patients. The EAR procedures were performed according
to previously described guidelines.15
Operative and postoperative measurements.
Standard intraoperative monitoring included a radial
artery cannula to continuously record blood pressure (BP)
and heart rate, and a I-II-V5/6 ST-segment electrocar-
diogram analysis. Monitoring was continued throughout
the period that the patient remained in the intensive care
unit. A balloon-tipped pulmonary artery catheter was
inserted in the pulmonary artery by standard techniques19
to record pulmonary wedge pressure (PWP), systemic vas-
cular resistance (SVR), stroke volume (SV), cardiac index
(CI), and the left ventricle stroke work index (SWI). All
intraoperative measurements were performed at three
points of time: before (baseline), during, and after aortic
occlusion. During EAR, inflation of the latex balloon
within the aorta (Stentor or Vanguard system) or deploy-
ment of the aortic part of the device until the point that
the aorta was occluded (AneuRx system) was considered
as aortic occlusion. In addition, during the same three
consecutive periods, myocardial performance was assessed
by transesophageal echocardiography (TEE) to record any
signs of WMAs of the left ventricular wall. TEE-images
were stored on a videotape and reviewed off-line by a sec-
ond cardiologist, who was blinded for the type of opera-
tion performed.
All patients were admitted at the intensive care unit for
continued monitoring at least until the next day. A 12-lead
electrocardiogram-analysis was obtained at 1 hour, 1 day,
and 1 week after operation. Blood samples for measuring
cardiac enzymes (creatinine kinase, creatinine kinase-MB,
lactate dehydrogenase, and transaminase) were obtained
24 hours after operation. One month after the procedure,
a transthoracic echocardiogram was performed and com-
pared with preoperative imaging.
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Outcome events. Risk factors (of which the association
with adverse outcome events were assessed) were the type
of operation, American Society of Anesthesiology (ASA)
classification, history of CAD, age of patient, and use of β-
blockers. The following outcome events were distin-
guished: The first group of clinical events included death of
all causes, cardiac death, myocardial infarction, congestive
heart failure, and a combination of the clinical cardiac
events 2 through 4; the second group of outcome events
consisted of electrocardiogram- or TEE-identified abnor-
malities (ie, ST abnormalities, WMAs of the left ventricular
wall, and a combination of events 6 through 7 that indi-
cated myocardial ischemia).
An ST abnormality was defined as ST-segment depres-
sion of 0.5 mm or more or ST-segment elevation of 2 mm
or more in the precordial leads and 1 mm or more in all
other leads, compared with the baseline reading and lasting
for at least 1 minute. Regional WMAs, as identified on
intraoperative TEE, were defined as a change of 2 or greater
in wall motion score in one or more of the 13 segments of
the left ventricle compared with previous echocardiography.
The definition of myocardial infarction was based on the
existence of at least one of the following criteria: ST abnor-
mality and elevation of cardiac enzymes greater than twice
their normal level or persistant WMAs on the 1-month
postoperative transthoracic echocardiogram. Congestive
heart failure required the symptoms or signs of pulmonary
edema, chest radiographs (which showed vascular redistrib-
ution, interstitial and alveolar edema), signs of new heart
failure (cardiomegaly, S3 gallop, jugular venous distension,
peripheral edema), and a change in medication.
Statistical analysis. Data were expressed as medians
and interquartile ranges. Differences in paired data sets (∆-
values) were expressed as mean values. The comparison of
data between groups was performed by chi-squared analy-
sis for categoric variables. The t tests were used for con-
tinuous variables with approximate normal distribution.
The Mann-Whitney nonparametric test was used to com-
pare other continuous or ordinal variables. Wilcoxon’s
signed-rank test was used for the analysis of paired data.
Statistical significance was reached when the probability
value (two-sided) was less than .05. Multivariate logistic
regression analyses were used to investigate correlations
Table II. Procedural data in the two study groups
Study group*
Procedural data EAR (n = 49) OAR (n = 71)
Duration of operation (min) 180 (150-240) 180 (150-210)
Packed cells (n) 0 (0-0) 2 (1-3)†
Duration of intubation (h) 8 (3-13) 12 (8-15.5)†
ICU stay (h) 20 (18-22) 22 (20-23)†
Clamping time (min) <1 50 (44-60)†
Hospital stay (d) 5 (3.5-8) 11 (9-15)†
ICU, Intensive care unit.
*Range is given in parentheses.
†P .01.
between a number of clinical variables, the clinical out-
come events, and electrocardiogram-TEE–derived out-
come events. The analysis of data was performed with the
statistical software SPSS (SPSS, Inc, Chicago, Ill) for
Windows 7.0 (Microsoft, Inc, Redmond, Wash).
RESULTS
Procedural data. The duration of tracheal intubation,
stay in the intensive care unit, and duration of hospital
admission were significantly shorter in patients who under-
went EAR (Table II). In addition, the volume of required
packed red cells was less in the EAR group. The duration of
the operative procedure was similar in the two study groups.
Intraoperative cardiac responses. Hemodynamic
parameters, including CI, SWI, SV, PWP, heart rate, BP,
and SVR measured before aortic occlusion (baseline mea-
surements), were all in the normal range in both study
groups. Besides a higher BP in patients who underwent
OAR, there were no significant intergroup differences
(Table III). However, the baseline physiologic myocardial
performance was less in patients who underwent EAR,
which was indicated by a significantly lower preaortic occlu-
sion value of the SWI of 33.1 gm/m2 (range, 26.8-39
gm/m2) in the EAR group compared with 37.4 gm/m2
(range, 31.7-46.5 gm/m2) in the OAR group (P = .03). A
graphic illustration of the procedural evolution of CI and
the SWI is presented in Fig 1. During aortic occlusion,
there was a comparable increase of the CI in both groups.
After aortic occlusion, however, the CI remained stable in
patients who underwent EAR, although it continued to
increase in patients who underwent OAR (mean rise from
preaortic occlusion to postaortic occlusion, 0.2 and 0.7 in
the two groups, respectively; P < .01). The changes in terms
of percentage of postaortic occlusion CI were +27% in OAR
versus +8% in patients who underwent EAR. The SWI dur-
ing the procedures represented a distinctly different cardiac
response in patients who underwent EAR and patients who
underwent OAR, with an increase of 1.9 in the former
group and a decrease of –1.4 in the latter (P = .04). This
inverse change in SWI continued after aortic occlusion,
with an increase of 2.58 and a decrease of –0.91, respec-
tively (P = .01). The changes in terms of percentage of
postaortic occlusion SWI were –2% in patients who under-
went OAR versus +7% in patients who underwent EAR.
Details of changes between groups are illustrated in Table
IV. In addition to this intergroup comparison, a paired sta-
tistical analysis was performed of changes within the same
groups. The SWI in patients who underwent OAR
decreased (37.4 before aortic occlusion and 33.7 after aor-
tic occlusion; P = .04), although no significant change was
found in patients who underwent EAR (33.1 before aortic
occlusion and 37.3 after aortic occlusion; P = .16 ).
Outcome events. The 30-day overall mortality rate in
this patient series consisted of five patients (4%). In three
of these patients (2.5%), the cause of death was of cardiac
origin (two patients in the OAR group and one patient in
the EAR group). One patient died of pulmonary insuffi-
ciency (EAR group), and one patient died of multi-organ
failure (OAR group). Two of the perioperative deaths had
an ASA-4 classification, two of the perioperative deaths
had an ASA-3 classification, and one of the perioperative
deaths had an ASA-2 classification. There was no differ-
ence in the overall or cardiac mortality rate between the
two study groups (Table V).
Myocardial infarction occurred in four patients, result-
ing in one death (25%). Congestive heart failure was
encountered in nine patients, three of whom died (30%).
The incidence of combined clinical cardiac complications
(including cardiac death, myocardial infarction, or conges-
tive heart failure) was 6% and 11% in the EAR group and
the OAR group, respectively; the difference was not sig-
nificant. Clinical complications occurred at a mean inter-
val of 4.6 days after operation.
In the perioperative period, ST elevation or depression
occurred in 39 patients (33% of observations). These
abnormalities were observed immediately after aortic
occlusion in 11 patients and on the first 24-hour electro-
cardiogram analysis in 33 patients. WMAs of the left ven-
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Table III. Hemodynamic parameters relative to aortic occlusion (AO) in patients who underwent EAR and who
underwent OAR
Study group
EAR (n = 49) OAR (n = 71)
Parameter Before AO During AO After AO Before AO During AO After AO
Heart rate (beats/min) 60 62 60 61 58 65
Mean BP (mm Hg) 74* 74 76† 84* 75 71†
SVR (dynes/cm5) 1182 1030 1050‡ 1328 1153 820‡
PWP (mm Hg) 13 14 14 14 13 16
CI (L/min/m2) 2.3 2.8 2.6§ 2.4 2.4 3.1§
SWI (g·m/m2) 33.1 35.3 37.3 37.4 35.7 33.7
SV (mL) 76 83 82 76 81 90
*P < .01.
†P = .03.
‡P < .01.
§P < .01. 
P = .03.
tricular wall was observed during TEE in 22 patients (22%
of recorded examinations). Nine patients with WMAs on
TEE had no ST abnormalities. Signs of myocardial
ischemia, as observed on electrocardiogram or TEE (either
ST abnormalities or WMAs), were present in 50 patients
(47% of observations), with a significantly lower incidence
in patients who underwent EAR (33% vs 57% in patients
who underwent OAR; Table V). Occurrence of myocardial
ischemia was clinically silent in 84% of the patients.
Multivariate analysis. Five pertinent clinical risk fac-
tors (ASA classification, patient’s age, history of CAD, type
of operation, and the use of β-blockers during the proce-
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dure) were entered into a multivariate logistic model for
correlation with two outcome events: combined clinical
cardiac complications and electrocardiogram/TEE-identi-
fied myocardial ischemia (Table VI). The ASA classification
appeared to be the only independent significant risk factor
with a positive association with combined clinical cardiac
complications. OAR, as the type of operation, was the sin-
gle risk factor that significantly correlated with electrocar-
diogram/TEE-identified myocardial ischemia.
These findings were thought to be particularly rele-
vant because the OAR group consisted of older patients.
This analysis indicated that age correlated neither with the
Fig 1. A, Comparison of SWI between the two study groups at three points of time relative to aortic occlusion. The value before aor-
tic occlusion is significantly worse in patients who underwent EAR (P = .03). In patients who underwent EAR, the SWI improves dur-
ing each successive step. In patients who underwent OAR, there is a gradual worsening of SWI. B, Comparison of CI between the two
study groups. During EAR, the CI is relatively stable. After clamp release (after aortic occlusion), there is a significant increase of the
measured value in the patients who underwent OAR.
A
B
occurrence of clinical cardiac complications nor with elec-
trocardiogram/TEE-detected ischemia.
DISCUSSION
Since the introduction of open repair of AAAs, the mor-
tality rate has decreased from approximately 10% in its early
days to below 5% in contemporary institutional
series.6,7,20,21 On the other hand, in regional and national
surveys, the reported mortality rate is still between 6% and
10%.5 Approximately 40% to 70% of perioperative deaths are
due to cardiac causes.6,7,9,22 The frequent occurrence of car-
diac complications has been attributed to a high incidence of
preexisting CAD in this particular patient category.23,24
Equally important is the impact of the procedure itself,
which imposes a considerable stress on the myocardium.
This stress is the combined result of anesthetic induction,
aortic clamping and declamping, blood loss that is inherent
to open aortic surgery, and the associated hemodynamic and
metabolic consequences.10,11 In contrast, endovascular
repair is believed not to produce such profound hemody-
namic alterations. Therefore, EAR may be expected to
impose less stress on the myocardium and to cause fewer car-
diac complications. In a recent study by the Eurostar reg-
istry2 that included 899 patients with an endovascular AAA
repair, the overall mortality rate was 3.2%,5 which is lower
than the mortality rate in most series with open surgery. This
low figure was achieved despite the fact that 9% of the
patients were at high operative risk, because their conditions
had an ASA class 4.2 The few studies that have compared
conventional and endovascular repair found no difference in
mortality rates between the two treatment methods.1,3,4
However, these studies suggested that EAR was associated
with less systemic complications, reduced blood loss, and
shorter intensive care and hospital stays. We were able to
confirm these findings in the present study. This may suggest
that the endovascular operation is better tolerated by the
patients than conventional repair.
The primary objective of our study was to compare the
cardiac implications of the procedures and, in particular,
the cardiac complications. For this purpose, we performed
a prospective study in two patient groups that were com-
parable for most clinical variables. The patients’ ages were
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Table IV. Comparison of the changes of hemodynamic parameters during and after aortic occlusions within the two
study groups
Changes during Changes after
aortic occlusion* (± SEM) aortic occlusion† (± SEM)
OAR EAR OAR EAR
PWP –1.74‡ ± 0.61 1.48‡ ± 0.59 0.98 ± 0.89 1.51 ± 0.83
CI 0.13 ± 0.10 0.22 ± 0.12 0.68§ ± 0.11 0.21§ ± 0.12
SWI –1.4 ± 2.43 1.86 ± 1.78 –0.91¶ ± 2.7 2.58¶ ± 1.8
SV 8.48 ± 4.42 0.68 ± 3.10 13.1 ± 3.14 4.23 ± 3.41
*Parameter value during aortic occlusion minus during aortic occlusion.
†Parameter value after aortic occlusion minus before aortic occlusion.
‡P < .01.
§P < .01.
P = .04.
¶P = .01.
Table V. Outcome events in the two study groups
Study group
EAR (n = 49) OAR (n = 71)
Outcome event n % n %
Death (all) 2/49 4 3/71 4
Death (cardiac) 1/49 2 2/71 3
Myocardial infarction 2/47 4 2/65 3
Congestive heart failure 3/49 6 6/71 8
Combined clinical cardiac outcome events* 3/47 6.4 7/66 11
ST abnormality 13/49 27 26/71 37
WMA on TEE† 7/44 16 15/58 26
Electrocardiogram/TEE-detected myocardial ischemia 15/45 33‡ 35/61 57‡
*Including the occurrence of cardiac death, myocardial infarction, and heart failure.
†TEE data for 18 patients were missing because of the inability of probe introduction (patients) or logistic reasons (13 patients).
‡P = .01.
higher in those who underwent OAR. However, the
regression model that was part of our analysis showed that
age had no significant effect on the study end points. As
shown in Table V, we found no difference between the
two treatment groups with regard to myocardial infarc-
tion, congestive heart failure, overall deaths, cardiac death,
and all clinical cardiac complications combined.
The detection of adverse cardiac events is highly depen-
dent on the sensitivity of the perioperative surveillance
because it is recognized that clinical adverse events only con-
stitute a small proportion of all perioperative ischemic events.
Not only do many ischemic events occur several days after
surgery, but most such events (up to 90%) are silent (ie, with-
out any clinical sign).25-27 For this reason, we used an exten-
sive protocol of intraoperative and postoperative monitoring
to detect subclinical episodes of myocardial ischemia to accu-
rately compare the two treatment modalities with regard to
their cardiac effects. In addition to electrocardiogram analy-
sis (as the most common method of detecting myocardial
ischemia), echocardiographic monitoring was included in our
protocol. In previous studies, regional WMAs of the
myocardium, as detected by TEE, have been demonstrated a
sensitive indicator of myocardial ischemia and a predictor of
cardiac complications.12-14 WMAs may occur before or even
without electrocardiographic or clinical manifestations. In
this series, nine cases of myocardial ischemia were identified
by TEE alone. In 47% of our patients, we found signs of
myocardial ischemia, of which 84% were clinically silent.
The important finding in this study was that, in compar-
ison with OAR, EAR carries a lower risk for perioperative
myocardial ischemia (33% vs 57%; P = .01). This observation
may be related to the relative minor cardiac function changes
associated with EAR that were found with the use of hemo-
dynamic measurements. In accordance with two recent stud-
ies, we demonstrated that hemodynamic alterations were
significantly less severe in patients who undergo EAR.28,29
Patients who underwent OAR, in our study, experienced an
important hyperdynamic circulatory state after the aorta was
unclamped, as demonstrated by a rise in CI (Table IV; Fig 1,
A). The rise in CI was significantly more important in the
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patients who underwent OAR than in the patients who
underwent EAR. It is of note that the CI reflects the general
hemodynamic state, which is highly dependent on the exist-
ing preload and afterload. The increase of CI after cross-
clamp release is caused by a decrease of SVR combined with
sufficient volume load. For these reasons, the SWI was calcu-
lated, as a more direct reflection of the left ventricular
myocardial contractility.30 During aortic occlusion, SWI sig-
nificantly decreased in the patients who underwent OAR, as
opposed to a nonsignificant increase in the patients who
underwent EAR. The changes were statistically significant
between the two study groups and indicated a depression of
myocardial contractility in the patients who underwent OAR
as opposed to the patients who underwent EAR. It may be
assumed that the increased CI causes a higher workload for
the myocardium and a higher oxygen consumption.31 This
may be detrimental for patients with CAD and may precipi-
tate myocardial ischemia by altering the relation between the
myocardial demand for oxygen and the supply. The simulta-
neous occurrence of hemodynamic changes and myocardial
ischemia appears to confirm a causal relationship between the
two events.
Myocardial ischaemia was detected more frequently in
patients who underwent OAR. However, this was not asso-
ciated with an increase in early cardiac death or other
adverse cardiac events in the perioperative period. This find-
ing may be due to the relatively small number of clinical
events in both treatment groups. Additionally, it is of note
that, on the basis of the preoperative cardiac screening and
intraoperative monitoring, more coronary interventions
and medication changes were performed in patients who
underwent OAR than in patients who underwent EAR. It
seems reasonable to assume that this affected our results by
having improved the cardiac status of the OAR group.
Consequently, relatively more adverse cardiac events may
have been prevented in the OAR group than in the EAR
group. Another interesting speculation in this respect may
be derived from the findings of Mangano and colleagues,32
who demonstrated that perioperative myocardial ischemia
increases the risk for serious cardiovascular outcomes by a
Table VI. Results of multivariate analysis that correlated risk factors to the probability of adverse events
Coefficients SE Odds ratio P value
Combined clinical cardiac complications*
ASA (class 4) 1.93 0.94 6.9 .04
Age (yr) .03 0.06 1.0 .63
History of CAD .39 0.80 1.5 .63
Type of operation (OAR) .70 0.82 2.0 .39
β-blockade .35 0.85 1.4 .68
Myocardial ischemia†
ASA (class 4) 1.22 0.81 3.8 .13
Age (yr) –.3 0.04 0.9 .42
History of CAD .83 0.46 2.3 .07
Type of operation (OAR) 1.31 0.47 3.7 <.01
β-blockade –.7 0.47 0.9 .89
*Includes the occurrence of cardiac death, myocardial infarction, or heart failure.
†As detected by electrocardiography and TEE.
factor of 2 to 20 over a period of 2 years after noncardiac
surgery. These considerations make it likely that EAR will
be associated with fewer adverse cardiac events in large
study groups, with completely comparable patient charac-
teristics and an extended follow-up time.
One may ask what practical consequences the
observed lower degree of cardiac stress may have on the
extent of the preoperative cardiac workup algorithm. In
our institution, screening by a cardiologist is the routine
schedule, with dobutamine stress echocardiography per-
formed in patients with a clinical suspicion of significant
CAD (ie, angina pectoris, previous myocardial infarction,
and/or congestive heart failure). In case important left
ventricular WMAs are observed, a coronary angiogram is
performed. One could argue that such a stringent proto-
col is no longer appropriate for a procedure that is signif-
icantly less stressful than open aortic surgery. Advanced
pretreatment cardiac diagnostic procedures may become
unnecessary in the large majority of patients with AAA.
In conclusion, important differences in cardiac
response were demonstrated between endovascular and
open AAA repair. Our findings indicate less myocardial
stress during endovascular repair. A lower frequency of
clinical adverse cardiac events in patients undergoing
endovascular repair may ultimately be expected.
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